| The effect of disopyramide on uterine contractions during pregnancy. | |
| | |
MedLine Citation:
|
PMID: 2309835 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
To evaluate the effect of disopyramide on uterine contractions during pregnancy, the drug was given for 48 hours to 10 women with indications for labor induction. Placebo was given to 10 other women with the same indications for induction. During the study period, regular uterine contractions occurred in 10 women in the study group, as compared with none in the control group (p less than 0.0001). Eight women in the study group were delivered of infants within 48 hours, as compared with none in the control group (p less than 0.0001). The mean time until the appearance of regular uterine contractions in the study group (4.15 +/- 1.76 hours) was significantly shorter (p less than 0.001) than that in the control group (56.13 +/- 5.28 hours). Patients who were not delivered of infants within 48 hours received other medications (prostaglandin E2, oxytocin). The mean maternal blood level of disopyramide at the time of appearance of uterine contractions was 1.52 +/- 0.9 mg/ml. The mean maternal level at delivery was 0.93 +/- 0.43 mg/ml and the cord blood level at the time of delivery was 0.33 mg/ml (cord blood/maternal level ratio = 0.36, r = 0.73, p less than 0.05). These results indicate that disopyramide should not be used in pregnancy for antiarrhythmic purposes because it may induce uterine contractions and delivery. |
| | |
Authors:
|
O P Tadmor; A Keren; D Rosenak; M Gal; M Shaia; E Hornstein; H Yaffe; E Graff; S Stern; Y Z Diamant |
Related Documents
:
|
22902085 - Evaluation and management of opioid dependence in pregnancy. 11803675 - Uterine distention facilitates the onset of maternal behavior in pseudopregnant but not... 394915 - Local antifertility effect of luteinizing hormone-releasing hormone (lrh). 22605595 - An interesting case of intramyometrial pregnancy. 1426385 - Freezing cocultured human blastocysts. 8981585 - Androstenedione synergizes with stress or prenatal drug exposure to retard fetal growth... |
Publication Detail:
|
Type: Clinical Trial; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: American journal of obstetrics and gynecology Volume: 162 ISSN: 0002-9378 ISO Abbreviation: Am. J. Obstet. Gynecol. Publication Date: 1990 Feb |
Date Detail:
|
Created Date: 1990-04-05 Completed Date: 1990-04-05 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0370476 Medline TA: Am J Obstet Gynecol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 482-6 Citation Subset: AIM; IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Bikur Cholim Hospital, Hadassah Medical School, Tel Aviv Medical Center, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Disopyramide / blood, pharmacology* Double-Blind Method Female Heart Rate, Fetal / drug effects Humans Labor, Induced Pregnancy / physiology* Uterine Contraction / drug effects* |
| Chemical | |
Reg. No./Substance:
|
3737-09-5/Disopyramide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Perinatal factors associated with the respiratory distress syndrome.
Next Document: Macrosomia: influence of maternal overweight among a low-income population.